text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 112529-15-4 | Product Number: P1901

Pioglitazone Hydrochloride

Purity: >98.0%(HPLC)(N)
  • 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride
3   1   ≥20 
1   1   ≥20 

*Upon orders receipt, Hyderabad stocks will be dispatched on the same day & Chennai stocks will be dispatched in 3-6 working days.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*Change currency to place order in USD.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Product Number P1901
Purity / Analysis Method >98.0%(HPLC)(N)
Molecular Formula / Molecular Weight C__1__9H__2__0N__2O__3S·HCl = 392.90  
Physical State (20 deg.C) Solid
CAS RN 112529-15-4
Related CAS RN 111025-46-8
Reaxys Registry Number 3579575
PubChem Substance ID 125307574
SDBS (AIST Spectral DB) 52915
Merck Index (14) 7452
MDL Number


Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(with Total Nitrogen) min. 98.0 %
Melting point 190.0 to 197.0 °C
Properties (reference)
Melting Point 191 °C
Related Laws:
Transport Information:
Pioglitazone Hydrochloride: An Agonist at the Peroxisome Proliferator-Activated Receptor of the Gamma Subtype (PPARγ)

Pioglitazone hydrochloride, a thiazolidinedione, is an agonist at the peroxisome proliferator-activated receptor of the gamma subtype (PPARγ), a transcription-regulating receptor. PPAR receptors are found in peripheral tissues important for insulin action. Activation of PPARγ nuclear receptors modulates the transcription of a number of insulin responsive genes involved in the control of glucose and lipid metabolism. Therefore, pioglitazone decreases insulin resistance in the periphery tissues and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. And recently, it has been reported that pioglitazone slows down the progression of Alzheimer's disease. For your reference, [A2567] is a key synthetic intermediate of pioglitazone. (The product is for research purpose only.)


PubMed Literature

Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents